Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alimera Sciences has said that the US health authorities have approved its new drug application for Alaway, an anti-allergic eye product.
Subscribe to our email newsletter
Indicated for the temporary relief of itchy eyes, Alaway will be marketed over-the-counter and includes a prescription strength active ingredient.
According to Alimera unlike over-the-counter anti-itch eye drop products currently available, just one dose of Alaway offers eye itch relief within minutes and lasts up to 12 hours. Other over-the-counter products currently available offer no more than four hours of relief and require four doses per day.
Alimera initially filed the new drug application for Alaway in February of this year after completing a successful clinical study that showed it to be bioequivalent to Novartis' Zaditor. Alaway is expected to be available to consumers in time for the spring 2007 allergy season.